Promote this Nomination

Additional Info

Company (that provides the nominated product / solution / service)Darktrace
Company size (employees)500 to 999
Type of solutionHybrid

In 3 bullets, summarize why this product or service is different from the competition and deserves recognition:

•Unlike traditional approaches that require prior knowledge about known threats, Darktrace’s technology addresses the evolving threat landscape by using unsupervised machine learning to identify subtle, stealthy, and never-before-seen threats that slip through the cracks of perimeter defenses.

•Darktrace’s Antigena is an innovative solution to both the increasing speed and sophistication of cyber-threats and the current shortage in cyber security professionals. Symantec predicts that by 2019, the number of unfilled cyber security jobs worldwide will be 1.5 million. Therefore, embracing autonomous response technologies, such as Antigena, is a necessary step forward in combatting such pressures.

•The Enterprise Immune System is scalable across all industries and organization sizes. Such product flexibility is tremendously important given that every organization, no matter industry or size, requires protection from cyber-threats.

Brief Overview

Darktrace’s Enterprise Immune System is the world’s leading AI technology for cyber defense. Inspired by the biological principles of the human immune system, this new class of technology has represented an industry shift in the way organizations defend themselves amid a new era of sophisticated and pervasive cyber-threats.

The technology of the Enterprise Immune System is fundamentally different to legacy approaches, which rely on pre-defining threats using rules and signatures. Instead, it works by leveraging machine learning and artificial intelligence to develop an understanding of the ‘pattern of life’ for every user, device, and network in an organization, forming an evolving understanding of what is ‘normal’. It can then detect genuine threats at their earliest stages – regardless of where they originate on the network. The Enterprise Immune System has identified 53,000 serious, in-progress threats across its 4,000 deployments – all of which were missed by traditional defenses – including ransomware, insider, and subtle, sophisticated threats.

Furthermore, the Enterprise Immune System platform provides security teams with complete network visibility and valuable intelligence of all activity via the 3D Threat Visualizer. With a graphical overview of the day-to-day activities in a network, it is easy-to-use and accessible for both security specialists and business executives. The Threat Visualizer also automatically alerts analysts to significant incidents and in-progress threats within their environment, enabling analysts to proactively investigate and neutralize threats in specific areas of the infrastructure, including cloud, IoT, and ICS.

Finally, Antigena, Darktrace’s autonomous response technology, completes the Enterprise Immune System platform by generating ‘digital antibodies’ that take measured, targeted action to neutralize in-progress cyber-threats. With one million unmanned cyber security positions worldwide, this functionality has proven invaluable by granting security teams critical time to catch up. Antigena works by taking precise, proportionate, and remedial action that neutralizes threats in real time.